Molecular imaging of the kidney in lupus nephritis to characterize response to treatment

Translational Research

Volumn 182, Issue , 2017, Pages 1-13

  Parikh, Samir V ^a   Malvar, Ana ^b   Song, Huijuan ^a   Alberton, Valeria ^b   Lococo, Bruno ^b   Vance, Jay ^a   Zhang, Jianying ^a   Yu, Lianbo ^a   Birmingham, Dan ^a   Rovin, Brad H ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHEMOKINE RECEPTOR CX3CR1; CISH PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR D; COMPLEMENT FACTOR I; CREATININE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLOPHOSPHAMIDE; FIBRONECTIN; FIBRONECTIN 1; GAMMA INTERFERON; HLA C ANTIGEN; HLA DRB1 ANTIGEN; HLA DRB3 ANTIGEN; IMMUNOPHILIN; INTERFERON; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 7; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MME PROTEIN; MYCOPHENOLATE MOFETIL; PREDNISONE; PROTEIN KINASE LCK; RETINOID RELATED ORPHAN RECEPTOR GAMMA; STAT1 PROTEIN; STAT2 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSFORMING GROWTH FACTOR BETA INDUCED PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; COMPLEMENT; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; INTRACELLULAR SIGNALING; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MOLECULAR IMAGING; PHENOTYPE; PRIORITY JOURNAL; PROTEINURIA; RENOGRAPHY; T LYMPHOCYTE; TREATMENT RESPONSE; UPREGULATION; YOUNG ADULT; BIOPSY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KIDNEY; LUPUS NEPHRITIS; METABOLISM; PATHOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ADULT; BIOMARKERS; BIOPSY; COMPLEMENT SYSTEM PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERFERONS; KIDNEY; LUPUS NEPHRITIS; MALE; MOLECULAR IMAGING; RNA, MESSENGER; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 85007238082     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2016.10.010     Document Type: Article

References (27)

1. 1 Berthier, C.C., Bethunaickan, R., Gonzalez-Rivera, T., et al. Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis. J Immunol 189 (2012), 988–1001.
2. 2 Bethunaickan, R., Berthier, C.C., Zhang, W., et al. Identification of stage-specific genes associated with lupus nephritis and response to remission induction in (NZB × NZW)F1 and NZM2410 mice. Arthritis Rheumatol 66 (2014), 2246–2258.
3. 3 Alvarado, A., Malvar, A., Lococo, B., et al. The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients. Lupus 23 (2014), 840–847.
4. 4 Malvar, A., Pirruccio, P., Alberton, V., et al. Histologic versus clinical remission in proliferative lupus nephritis. Nephrol Dial Transplant, 2015 [Epub ahead of print]. Available at http://www.ncbi.nlm.nih.gov/pubmed/26250434.
5. 5 Hahn, B.H., McMahon, M.A., Wilkinson, A., et al., American College of Rheumatology. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res 64 (2012), 797–808.
6. 6 Parikh, S.V., Malvar, A., Song, H., et al. Characterising the immune profile of the kidney biopsy at lupus nephritis flare differentiates early treatment responders from non-responders. Lupus Sci Med, 2, 2015, e000112.
7. 7 Dave, V., Volberg, V., Huen, K., Holland, N., Use of the nCounter system for the analysis of multiple RNA expression profiles in peripheral blood mononuclear cells. Environ Mol Mutagen, 54, 2013, S29.
8. 8 Golubeva, Y., Salcedo, R., Mueller, C., Liotta, L.A., Espina, V., Laser capture microdissection for protein and NanoString RNA analysis. Methods Mol Biol 931 (2013), 213–257.
9. 9 Vaes, E., Khan, M., Mombaerts, P., Statistical analysis of differential gene expression relative to a fold change threshold on NanoString data of mouse odorant receptor genes. BMC Bioinformatics, 15, 2014, 39.
10. 10 Sartor, M.A., Tomlinson, C.R., Wesselkamper, S.C., Sivaganesan, S., Leikauf, G.D., Medvedovic, M., Intensity-based hierarchical Bayes method improves testing for differentially expressed genes in microarray experiments. BMC Bioinformatics, 7, 2006, 538.
11. 11 Bao, L., Osawe, I., Puri, T., Lambris, J.D., Haas, M., Quigg, R.J., C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. Eur J Immunol 35 (2005), 2496–2506.
12. 12 Pickering, M.C., Ismajli, M., Condon, M.B., et al. Eculizumab as rescue therapy in severe resistant lupus nephritis. Rheumatology 54 (2015), 2286–2288.
13. 13 Mak, A., Kow, N.Y., The pathology of T cells in systemic lupus erythematosus. J Immunol Res, 2014, 2014, 419029.
14. 14 Liu, Z., Zhang, H., Liu, Z., et al. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial. Ann Intern Med 162 (2015), 18–26.
15. 15 Adhya, Z., Borozdenkova, S., Karim, M.Y., The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis. Nephrol Dial Transplant 26 (2011), 3273–3280.
16. 16 Luther, S.A., Bidgol, A., Hargreaves, D.C., et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 169 (2002), 424–433.
17. 17 Ishikawa, S., Sato, T., Abe, M., et al. Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J Exp Med 193 (2001), 1393–1402.
18. 18 Worthmann, K., Gueler, F., von Vietinghoff, S., et al. Pathogenetic role of glomerular CXCL13 expression in lupus nephritis. Clin Exp Immunol 178 (2014), 20–27.
19. 19 Schiffer, L., Worthmann, K., Haller, H., Schiffer, M., CXCL13 as a new biomarker of systemic lupus erythematosus and lupus nephritis - from bench to bedside?. Clin Exp Immunol 179 (2015), 85–89.
20. 20 Hom, G., Graham, R.R., Modrek, B., et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358 (2008), 900–909.
21. 21 Baechler, E.C., Batliwalla, F.M., Karypis, G., et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100 (2003), 2610–2615.
22. 22 Markovic-Lipkovski, J., Muller, C.A., Klein, G., et al. Neural cell adhesion molecule expression on renal interstitial cells. Nephrol Dial Transplant 22 (2007), 1558–1566.
23. 23 Buzhor, E., Omer, D., Harari-Steinberg, O., et al. Reactivation of NCAM1 defines a subpopulation of human adult kidney epithelial cells with clonogenic and stem/progenitor properties. Am J Pathol 183 (2013), 1621–1633.
24. 24 Markovic-Lipkovski, J., Zivotic, M., Muller, C.A., et al. Variable expression of neural cell adhesion molecule isoforms in renal tissue: possible role in incipient renal fibrosis. PLoS One, 10, 2015, e0137028.
25. 25 Otten, M.A., van Egmond, M., The Fc receptor for IgA (FcalphaRI, CD89). Immunol Lett 92 (2004), 23–31.
26. 26 Lang, D., Knop, J., Wesche, H., et al. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J Immunol 161 (1998), 6871–6877.
27. 27 Peterson, K.S., Huang, J.F., Zhu, J., et al. Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest 113 (2004), 1722–1733.